H1 Oct4-EGFP

This cell line is a modified version of WA01 (H1) engineered using homologous recombination to insert a GFP Neomycin cassette under control of the POUF1 gene (Oct4). Cells expressing Oct4 express GFP and are positively selectable using neomycin. These cells can readily differentiate and may require continued maintenance in the absence of selection.
Cell Type Modified Human ES
Disease None reported
Genetic Modification Keyword Reporter; Self-renewal - Pluripotency
Sex Male
Genetically Related Cell Lines  
Provider University of Wisconsin - Dr. James Thomson
dbGaP Data  
hPSCReg ID  
NIH Approval  
Pub Med Abstract  
Related Products
Collection(s) NIH Approved
Have you received this cell line previously? Yes No Why we ask
Quantity: Learn about our volume discounts

Current Lot Information

Lot Number Culture Platform Lot Description Passage Number Banked By Protocol Product Information & Testing
DL-02 mTeSR1/Matrigel Oct4 mediated GFP 69(10) WiCell WiCell Feeder Independent Pluripotent Stem Cell Protocol with Supplement Culturing with G418 PDF

Historical Lot Information

Lot Number Culture Platform Lot Description Banked By Protocol Product Information & Testing
MCB-01 mTeSR1/Matrigel Oct4 mediated GFP WiCell WiCell Feeder Independent Pluripotent Stem Cell Protocol with Supplement Culturing with G418 PDF